{"id":"W2940567933","doi":"10.1097/01.ju.0000555909.47437.02","title":"MP34-17 A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF ENZALUTAMIDE IN PATIENTS WITH NONMETASTATIC CASTRATION-RESISTANT PROSTATE CANCER: POST HOC ANALYSIS OF PROSPER BY PROSTATE SPECIFIC-ANTIGEN PROGRESSION","year":2019,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Medicine; Enzalutamide; Prostate cancer; Post-hoc analysis; Placebo; Prostate; Prostate-specific antigen; Oncology; Cancer; Urology; Internal medicine; Post hoc; Pathology; Androgen receptor","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002712917,0.001623078,0.002148597,0.00060245,0.0006092893,0.0009689817,0.0007439935,0.001895498,0.009844189],"category_scores_gemma":[0.002395819,0.0007519696,0.003185891,0.0004531043,0.0008815692,0.0009897145,0.0003869409,0.003206872,0.0009507762],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006225538,"about_ca_system_score_gemma":0.002993587,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001545385,"about_ca_topic_score_gemma":0.003965021,"domain_scores_codex":[0.9991021,0.0005663095,0.00005122182,0.0001024341,0.00008686069,0.00009107134],"domain_scores_gemma":[0.998744,0.0003994387,0.0003481204,0.00008077266,0.0001267129,0.0003009908],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.9670036,0.00621888,0.0003910089,0.001059321,0.001247806,0.00003126559,0.00004785138,0.0002933095,0.002945273,0.0001901665,0.002070141,0.01850138],"study_design_scores_gemma":[0.9398728,0.05702337,0.0008769353,0.00004702176,0.0004088732,0.00001594274,0.00001404214,0.0002247178,0.0004058726,0.0001204746,0.0009753697,0.00001450923],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9422736,0.02025032,0.002391232,0.001901782,0.001526466,0.01995273,0.004676103,0.0004746671,0.00655313],"genre_scores_gemma":[0.9353013,0.01424542,0.008216315,0.003534083,0.0009756946,0.02113548,0.003520329,0.0001444827,0.01292681],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.009844189,"threshold_uncertainty_score":0.0329321,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01571752767536278,"score_gpt":0.3285312000984466,"score_spread":0.3128136724230838,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}